Cargando…
Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants
OBJECTIVES: Infants exposed to combination therapy with anti-tumor necrosis factor (anti-TNF) agents and thiopurines may exhibit increased infections at 1 year of age compared to unexposed infants. We hypothesized that this increased risk of infection is due to abnormal development of the newborn im...
Autores principales: | Kattah, Michael G., Milush, Jeffrey M., Burt, Trevor, McCabe, Robert P., Whang, Michael I., Ma, Averil, Mahadevan, Uma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886978/ https://www.ncbi.nlm.nih.gov/pubmed/29618720 http://dx.doi.org/10.1038/s41424-018-0018-3 |
Ejemplares similares
-
Correction: Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants
por: Kattah, Michael G., et al.
Publicado: (2018) -
A practical guide to thiopurine prescribing and monitoring in IBD
por: Warner, Ben, et al.
Publicado: (2018) -
Thiopurine Exposure During Pregnancy is Not Associated With Anemia in Infants Born to Mothers With IBD
por: Yeaman, Fiona, et al.
Publicado: (2023) -
Allopurinol in combination with thiopurine induces mucosal healing and improves clinical and metabolic outcomes in IBD
por: Moreau, Brigitte, et al.
Publicado: (2017) -
Lead, a major environmental pollutant, is immunomodulatory by its differential effects on CD4(+) T cell subsets
por: McCabe, Michael J., et al.
Publicado: (1991)